303 related articles for article (PubMed ID: 28802908)
1. Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances.
Wu H; Medeiros LJ; Young KH
Blood Rev; 2018 Jan; 32(1):8-28. PubMed ID: 28802908
[TBL] [Abstract][Full Text] [Related]
2. The rise of apoptosis: targeting apoptosis in hematologic malignancies.
Valentin R; Grabow S; Davids MS
Blood; 2018 Sep; 132(12):1248-1264. PubMed ID: 30012635
[TBL] [Abstract][Full Text] [Related]
3. Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?
Brinkmann K; Kashkar H
Cell Death Dis; 2014 Mar; 5(3):e1098. PubMed ID: 24603326
[TBL] [Abstract][Full Text] [Related]
4. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
Hata AN; Engelman JA; Faber AC
Cancer Discov; 2015 May; 5(5):475-87. PubMed ID: 25895919
[TBL] [Abstract][Full Text] [Related]
5. Involvement of BH3-only proteins in hematologic malignancies.
Kuroda J; Taniwaki M
Crit Rev Oncol Hematol; 2009 Aug; 71(2):89-101. PubMed ID: 19022681
[TBL] [Abstract][Full Text] [Related]
6. Targeting the apoptosis pathway in hematologic malignancies.
Zaman S; Wang R; Gandhi V
Leuk Lymphoma; 2014 Sep; 55(9):1980-92. PubMed ID: 24295132
[TBL] [Abstract][Full Text] [Related]
7. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.
Merino D; Lok SW; Visvader JE; Lindeman GJ
Oncogene; 2016 Apr; 35(15):1877-87. PubMed ID: 26257067
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics targeting Bcl-2 in hematological malignancies.
Ruefli-Brasse A; Reed JC
Biochem J; 2017 Oct; 474(21):3643-3657. PubMed ID: 29061914
[TBL] [Abstract][Full Text] [Related]
9. BCL-2 as therapeutic target for hematological malignancies.
Perini GF; Ribeiro GN; Pinto Neto JV; Campos LT; Hamerschlak N
J Hematol Oncol; 2018 May; 11(1):65. PubMed ID: 29747654
[TBL] [Abstract][Full Text] [Related]
10. Cancer therapeutics: Targeting the apoptotic pathway.
Khan KH; Blanco-Codesido M; Molife LR
Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis.
Gibson CJ; Davids MS
Clin Cancer Res; 2015 Nov; 21(22):5021-9. PubMed ID: 26567361
[TBL] [Abstract][Full Text] [Related]
12. Targeting apoptosis proteins in hematological malignancies.
Droin N; Guéry L; Benikhlef N; Solary E
Cancer Lett; 2013 May; 332(2):325-34. PubMed ID: 21767908
[TBL] [Abstract][Full Text] [Related]
13. Emerging targets for hematological malignancies.
Cilloni D; Frassoni F; Saglio G
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
[TBL] [Abstract][Full Text] [Related]
14. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic inhibition of BCL-2 and related family members.
Levy MA; Claxton DF
Expert Opin Investig Drugs; 2017 Mar; 26(3):293-301. PubMed ID: 28161988
[TBL] [Abstract][Full Text] [Related]
16. Hematologic malignancies: newer strategies to counter the BCL-2 protein.
Ebrahim AS; Sabbagh H; Liddane A; Raufi A; Kandouz M; Al-Katib A
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2013-22. PubMed ID: 27043233
[TBL] [Abstract][Full Text] [Related]
17. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
[TBL] [Abstract][Full Text] [Related]
18. Targeting Wnt signaling pseudokinases in hematological cancers.
Karvonen H; Perttilä R; Niininen W; Barker H; Ungureanu D
Eur J Haematol; 2018 Oct; 101(4):457-465. PubMed ID: 29989208
[TBL] [Abstract][Full Text] [Related]
19. Targeting Bcl-2 for cancer therapy.
Zhang L; Lu Z; Zhao X
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188569. PubMed ID: 34015412
[TBL] [Abstract][Full Text] [Related]
20. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
